📊 Score Breakdown
Offering Ability
60
Cash Runway
95
Float Risk
64
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
30%
💰 Capital Raise
55%
• Critical: only 2.8 months cash remaining
📉 Score Deterioration
10%
• Score in HIGH risk zone (73/100)
💹 Market Data
Market Cap$4.01B
Shares Outstanding593.35M
Float111.23M
Cash$5.39M
Debt$11.29M
Short InterestN/A
🏛 Institutional Holdings
0.7% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
📉 Short Interest
Short Interest387.2K
Days to Cover2.9
% of Float0.3%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2023
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for EMAT
📊 EMAT FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 EMAT Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.